Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001155
Filing Date
2025-01-08
Accepted
2025-01-08 18:41:04
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 form4-01082025_110101.html 4  
1 form4-01082025_110101.xml 4 4143
  Complete submission text file 0001415889-25-001155.txt   5601
Mailing Address 405 LEXINGTON AVENUE 50TH FLOOR NEW YORK NY 10174
Business Address
Kalir Erez (Reporting) CIK: 0001512447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 25519620

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)